Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review
Health Science Reports · 2026-10 · 9 (10)
DOI: 10.1002/hsr2.73254 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Health Science Reports, online erschienen am 25.09.2026. Verfasst von Kafayat Aminu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Evidence Synthesis and Implementation Research Cephas Health Research Initiative Inc Ibadan Nigeria. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Human papillomavirus (HPV) vaccination is a critical intervention for cervical cancer prevention in Africa; however, program uptake and scale‐up remain limited due to financing constraints. This scoping review mapped existing evidence on HPV vaccine financing in Africa, identifying prevailing funding mechanisms, cost estimates, delivery strategies, and challenges and opportunities for sustainable financing.
Methods
Guided by the Arksey and O'Malley framework and PRISMA‐ScR guidelines, we systematically searched nine electronic databases for peer‐reviewed studies. Retrieved records were deduplicated and screened against eligibility criteria. Eligible studies underwent data extraction, followed by collation, summarization, and thematic synthesis. All costs were standardized to United States (US) Dollars and further adjusted to a common reference year (2025US) using the US Consumer Price Index (CPI‐U) to enable comparison across study years.
Results
Twenty‐seven peer‐reviewed studies were included. The review found heavy dependence on donor support, particularly from Gavi, with limited domestic co‐financing across most countries. Per‐dose costs ranged from US$0.27–US$19.76 (financial) and US$1.31–US$45.00 (economic) as reported, or US$0.32–US$26.50 and US$1.63–US$60.36 after adjustment to 2025 US; per fully immunized girl, costs ranged from US$6.68–US$40.03 and US$17.31–US$91.19 as reported, or US$8.31–US$53.69 and US$21.53–US$122.31 adjusted. Primary cost drivers included service delivery, personnel, and outreach to out‐of‐school girls. School‐based delivery was more cost‐effective in several contexts, and the single‐dose schedule consistently showed lower cost with comparable efficacy, enhancing cost‐effectiveness and reducing programmatic burden. Willingness to pay exists among private individuals, but out‐of‐pocket models remain inequitable.
Conclusion
Donor funds, mainly Gavi, still drive HPV vaccination in most of Africa. The single‐dose schedule cuts costs and logistics while remaining effective. For equitable, sustainable access, African countries must prioritize cost‐effective vaccines, boost domestic funding, strengthen health systems, and adopt models that lessen reliance on external support.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Evidence Synthesis and Implementation Research Cephas Health Research Initiative Inc Ibadan Nigeria.
- Department of Sociology Usmanu Danfodiyo University Sokoto Nigeria.
- Department of Sociology University of Johannesburg Johannesburg South Africa.
- Centre for Digital Health Research Innovation and Practice, Cephas Health Research Initiative Inc Ibadan Nigeria.
- The African Field Epidemiology Network Nigeria Country Office Abuja Nigeria.
- Department of Community Medicine University of Ibadan Ibadan Nigeria.
ORCID-Profile: Kafayat Aminu, Jimoh Amzat, Rita Amarachi Nwebo, Precious Chika Nnannah, Olubukola Omobowale, Abba Shehu, Yovanthi Anurangi Jayasinghe, Kehinde Kazeem Kanmodi
Zitieren
APA
Aminu, K., Amzat, J., Nwebo, R. A., Nnannah, P. C., Ezeagu, C. N., Edukugho, A. A., Omobowale, O., Shehu, A., Jayasinghe, Y. A., Amzat, G., & Kanmodi, K. K. (2026). Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review. Health Science Reports, 9(10). https://doi.org/10.1002/hsr2.73254
Vancouver
Aminu K, Amzat J, Nwebo RA, Nnannah PC, Ezeagu CN, Edukugho AA, et al. Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review. Health Science Reports. 2026;9(10). doi:10.1002/hsr2.73254
BibTeX
@article{Aminu2026,
author = {Aminu, Kafayat and Amzat, Jimoh and Nwebo, Rita Amarachi and Nnannah, Precious Chika and Ezeagu, Chiamaka Norah and Edukugho, Aboyowa Arayuwa and Omobowale, Olubukola and Shehu, Abba and Jayasinghe, Yovanthi Anurangi and Amzat, Ganiyat and Kanmodi, Kehinde Kazeem},
title = {Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review},
journal = {Health Science Reports},
year = {2026},
volume = {9},
number = {10},
doi = {10.1002/hsr2.73254}
}
EUVIMED